CE19 - Technologies pour la santé 2021

Smart Bone Organoid Bioreactor – SMART_BONE_ORGANOID

Submission summary

In the last decade, the development of organoids has generated real enthusiasm, allowing the study of new treatments and the implementation of a personalized medicine approach while reducing experiments on animals. The generation of bone organoids from human mesenchymal stem cells capable of mimicking certain bone functionalities requires exposing the cells to physiologically relevant conditions. The proposed project aims to develop a smart bone bioreactor capable, for the first time, of measuring and adapting, in a dynamic and controlled manner, the mechanical stress, oxygen tension and nutrient supply to the cells throughout the entire genesis of the bone organoid. This project will rely on the consortium's leading-edge expertise in the field of bone and in particular on the development of a pre-existing bioreactor. The ultimate validation phase will be an efficient treatment against bone fragility on the organoid generated from the Smart Bone Bioreactor.

Project coordination

Thierry Hoc (Biologie, Bioingénierie et Bioimagerie Ostéo-articulaires)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

B3OA Biologie, Bioingénierie et Bioimagerie Ostéo-articulaires
BRIO PATHOLOGIES, IMAGERIE ET BIOTHERAPIES ORO-FACIALES
MEDyC Matrice Extracellulaire et DYnamique Cellulaire

Help of the ANR 597,350 euros
Beginning and duration of the scientific project: October 2021 - 48 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter